Efficacy and Safety of Everolimus in Patients With Metastatic Colorectal Cancer Who Have Failed Prior Targeted Therapy and Chemotherapy
Clinical trial NCT00419159 · COMPLETED
Trial details
- NCT number
- NCT00419159
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-12-01
- Primary completion
- 2009-03-01
- Enrollment
- 199
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.